Related Experiment Video
Updated: Jan 20, 2026

Transurethral Instillation Procedure in Adult Male Mouse
Published on: November 2, 2017
[Post-Operative Immediate Single Instillation of Chemotherapy as Prevention of Recurrence after Transurethral
Shimpei Sugiura1, Noriaki Noto1, Mitsuyuki Koizumi1
1The Department of Urology, Yokohama Minami-Kyosai Hospital.
Single instillation of pirarubicine hydrochloride (THP) significantly reduced recurrence rates in non-muscle-invasive bladder cancer (NMIBC) patients compared to historical controls. This chemoprevention strategy shows promise for improving outcomes in high-risk NMIBC.
Area of Science:
- Urology
- Oncology
- Cancer Chemoprevention
Background:
- Non-muscle-invasive bladder cancer (NMIBC) requires effective chemoprevention strategies to reduce recurrence.
- Bacillus Calmette-Guerin (BCG) and intravesical chemotherapy are standard treatments, but their efficacy and optimal timing vary.
- Immediate single instillation (SI) of chemotherapy post-transurethral resection of bladder tumor (TURBT) is an area of investigation.
Purpose of the Study:
- To evaluate the efficacy of immediate single instillation (SI) of pirarubicine hydrochloride (THP) for NMIBC chemoprevention.
- To compare recurrence rates between patients receiving SI of THP and those receiving standard BCG induction or delayed chemotherapy.
- To identify recurrence risk factors in NMIBC management.
Main Methods:
- Retrospective analysis of 256 intermediate and high-risk NMIBC patients treated between 1999 and 2014.
- Comparison of outcomes between an SI of THP group (introduced in 2010) and a control group (BCG induction or delayed chemotherapy).
- Follow-up included cystoscopy and urine cytology, with statistical analysis using univariate and multivariate models.
Main Results:
- The 3- and 5-year non-recurrence rates were 80.3% for the SI group versus 69.7% and 64.5% for the control group, respectively.
- Univariate analysis showed a significant difference in recurrence rates between the groups (P=0.025).
- Multivariate analysis identified the choice of chemotherapy over BCG and the absence of SI as significant recurrence risk factors.
Conclusions:
- Immediate single instillation of pirarubicine hydrochloride is an effective chemoprevention strategy for reducing recurrence in NMIBC.
- This approach demonstrates superior outcomes compared to historical controls receiving standard intravesical therapies.
- Further research, including randomized trials, is warranted to confirm these findings, acknowledging the retrospective nature of this study.
Related Concept Videos
04:09Minimal Invasive Resection of Large Retrosternal Thyroid Goiter
04:46Glioblastoma Relapse Post-Resection Model for Therapeutic Hydrogel Investigations
09:243-D Cell Culture System for Studying Invasion and Evaluating Therapeutics in Bladder Cancer
04:01Transurethral Instillation Procedure in Adult Male Mouse
08:55Murine Model for Non-invasive Imaging to Detect and Monitor Ovarian Cancer Recurrence
08:15Minimally Invasive Establishment of Murine Orthotopic Bladder Xenografts

